Primary Care of the Newly Diagnosed HIV-Infected Patient in Developed Countries

  • Author: Mary W. Montgomery, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/20/18 (What's New)

Summary

  • Patients with CD4+ cell counts < 200 cells/mm3 are at risk for OIs and require primary prophylaxis
  • Patients who have been treated for OIs often require secondary prophylaxis (Table)
  • Treatment guidelines state that primary and secondary prophylaxis can be discontinued in patients with successful immune reconstitution on ART, provided there is no evidence of active disease (Management Guidelines)[CDC OI]

Action required

Keywords: Mycobacterium avium Complex

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.